MeiraGTx Earnings
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
10.69+0.19 (+1.81%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MeiraGTx earnings summary
In its most recent report on Aug 13, 2026 (Q2 2026), MGTX posted EPS of $1.71. Revenue for the quarter was $321.4 million. Across the last 16 reports, MGTX shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
MGTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $1.71 | — | +6.1% |
| May 14, 2026 | — | $-0.57 | — | -1.7% |
| Mar 30, 2026 | — | $0.19 | — | -2.3% |
| Nov 13, 2025 | — | $-0.62 | — | -8.9% |
| Aug 14, 2025 | — | $-0.48 | — | -4.2% |
| May 13, 2025 | — | $-0.51 | — | +2.2% |
| Mar 13, 2025 | — | $-0.49 | — | -3.0% |
| Nov 13, 2024 | — | $-0.55 | — | -8.5% |
| Aug 12, 2024 | — | $-0.76 | — | -1.4% |
| May 9, 2024 | — | $-0.32 | — | +12.6% |
| Mar 15, 2024 | — | $0.40 | — | +0.2% |
| Nov 14, 2023 | — | $-0.74 | — | -3.9% |
| Aug 10, 2023 | — | $-0.53 | — | -3.0% |
| May 11, 2023 | — | $-0.62 | — | +31.0% |
| Mar 14, 2023 | — | $-0.58 | — | -6.1% |
| Nov 10, 2022 | — | $-0.83 | — | +1.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.